Nanomedicine as the basis of personalised medicine

Abstract

Recent years have witnessed unprecedented growth in research in the area of nanoscience. One of the most active applications of nanoscience, the ”science of the small particles usually less than 100 nm in diameter” is nanomedicine. Recent advances in biomedical research have generated opportunity to understand the factors underlying the development and progression of disease in individual patients. In addition, identifying factors which predict the individual response to treatment enable new approach to medicine through the stratification of treatment and prevention. This is the basis of personalised medicine. Several nanotechnology drugs and devices have already received regulatory approval; others are currently being investigated in clinical trials. This article addresses some points for utilisation of nanotechnology in personalised medicine.
Kardiol Pol 2011; 69, 10: 1107–1108